-
Doxycycline Hyclate: From MMP Signal to BBB Assay
2026-09-15
Doxycycline hyclate is a matrix metalloproteinases inhibitor with practical value in blood–brain barrier and neurotoxicity research. This article translates an arsenic-exposure mouse study into assay-design decisions while distinguishing target engagement, barrier protection, and cross-domain antiviral or antimalarial applications.
-
Saracatinib (AZD0530) Assay Workflow Guide
2026-09-15
Build reproducible Src/Abl pathway experiments with Saracatinib (AZD0530), from dose-response and migration assays to phospho-signaling validation. The workflow also explains how SFK inhibition can be used cautiously to extend Reelin–SFK research into experimentally distinct cancer biology and synaptic models.
-
Western Secondary Antibody Dilution Buffer Workflow
2026-09-14
Build cleaner, more reproducible Western blots for macrophage signaling studies with a stabilizing, reuse-oriented secondary antibody formulation. This workflow connects buffer selection to NHE1, Olfr2, calcium-dependent ROS, and NLRP3 assay design while providing practical optimization and troubleshooting guidance.
-
Eicosapentaenoic Acid (EPA) Workflow Guide
2026-09-14
Build reproducible EPA experiments around two validated concentration windows: low-micromolar oxidation assays and higher-dose endothelial migration models. This practical guide connects membrane remodeling, lipid-lowering studies, and carefully bounded translational insights from recent arachidonic acid immunology research.
-
Artesunate Workflows for Cancer Response Profiling
2026-09-13
Artesunate enables mechanism-aware cancer assays that separate growth suppression from true cell killing. This practical workflow supports small cell lung carcinoma research, esophageal squamous cell carcinoma models, and ferroptosis-oriented studies with controlled dosing, orthogonal readouts, and troubleshooting guidance.
-
Sex Differences in Angiotensin II Hypertension
2026-09-12
Xue, Pamidimukkala, and Hay used telemetry in conscious, freely moving mice to show that chronic angiotensin II caused a substantially larger blood-pressure increase in males than females despite comparable baseline pressure. Gonadectomy, baroreflex testing, and ganglionic blockade linked this divergence to sex-dependent hormonal and sympathetic regulation, providing a framework for separating vascular, autonomic, and endocrine contributions to hypertension.
-
Nystatin: Designing Better Antifungal Assays
2026-09-12
Nystatin (Fungicidin) is more than a membrane-active antifungal control: its solubility, species selectivity, and delivery context can reshape assay interpretation. This guide connects Candida phenotyping with nanoparticle uptake research to support more rigorous experimental design.
-
Cefepime: An Evidence-Guided Assay Framework
2026-09-11
Cefepime (BMY-28142) supports a more rigorous approach to central nervous system infection research. This article develops an evidence-guided assay framework that separates direct cefepime findings from transferable lessons in resistant Enterobacterales research.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-11
CAY10499 enables controlled dissection of HSL, MGL, FAAH, and lipid-transmitter pathways in biochemical and cellular models. Its strongest use-case is as an orthogonal lipid-hydrolysis perturbation in EV-driven macrophage studies, where it can distinguish fatty-acid mobilization from ACLY-dependent lipid synthesis.
-
Oseltamivir acid: Mechanism, Models, and Assays
2026-09-10
Oseltamivir acid is an influenza neuraminidase inhibitor suited to mechanism-led antiviral research. This article connects enzyme, cell, resistance, and translational assay design while applying lessons from humanized-mouse prodrug research without conflating distinct metabolic systems.
-
EZ Cap™ Human PTEN mRNA: Mechanism & Workflow
2026-09-10
EZ Cap™ Human PTEN mRNA (ψUTP) is an in vitro transcribed mRNA reagent designed for controlled human PTEN expression in mammalian research models. Its Cap 1 structure, pseudouridine modification, and poly(A) tail support mRNA stability enhancement and translation-focused studies, while published nanoparticle work connects PTEN mRNA delivery with PI3K/Akt signaling pathway inhibition in trastuzumab-resistant breast cancer models.
-
WST-8 Glucose Uptake Assay Kit for NAFLD
2026-09-09
Translate insulin-resistance biology into a quantitative, non-radioactive glucose uptake readout with a workflow suited to hepatocyte and metabolic-stress models. This guide connects Galectin-1–FIP200 autophagy research with practical assay design, normalization, and troubleshooting.
-
Indole-3-Pyruvic Acid: A Cross-System Research Guide
2026-09-09
Indole-3-pyruvic acid is more than an auxin precursor: it is a flux-sensitive metabolite linking indole-3-acetic acid biosynthesis, fungal genetics, and immune modulation via AhR. This guide translates pathway evidence into better assay design, controls, and interpretation across plant and mammalian research.
-
Propranolol Reprograms Burn Metabolism
2026-09-08
This phase II randomized study links propranolol’s clinical effects after severe burn injury to coordinated changes in adipose-tissue energy, nucleotide, lipid, and catecholamine-related pathways. Its multi-omics design identifies reduced lipolysis and endoplasmic reticulum stress as mechanistic bridges between beta-blockade and a less inflammatory metabolic state.
-
Bifendate (DDB): From Hepatoprotection to Translation
2026-09-08
Bifendate (DDB) offers a translational research framework that connects hepatoprotection, lipid metabolism regulation, and context-dependent autophagy inhibition. This article examines how to position DDB in liver disease models, interpret its relationship to berberrubine research, and design more rigorous pharmacology and drug–drug interaction studies.